Treatment Options for Diabetic Retinopathy When diabetic retinopathy complications arise, our best ophthalmologists offer cutting-edge treatment modalities: Anti-VEGF Injections These medications, including ranibizumab, aflibercept, and faricimab, help reduce abnormal blood vessel growth and decrease macular oedema
We will first review the current status of subcutaneous administration, and then focus on the latest research progress in the development of oral peptide drugs (Table 8)
Necrosis was documented in 33.3% of patients in the ASV group and 20.0% in the ASV + NAC group, while ecchymosis was observed in 60.0% and 66.7% of patients, respectively, with no statistically significant differences between groups Table 3
Cellular brightening through Glutathione: Unlike conventional brightening actives that target one stage of melanin production, Glutathione reduces oxidative stress at the root, creating a less favourable environment for melanin overproduction and supporting long-term brightness
Painful thyroiditis is often preceded by a viral illness